临床实践
Copyright ©The Author(s) 2024.
世界华人消化杂志. 2024-03-28; 32(3): 236-242
在线出版 2024-03-28. doi: 10.11569/wcjd.v32.i3.236
表2 两组氧合状态指标比较(mean±SD)
指标组别例数T0T1T2T3F时间F组间F交互
SpO2(%)舒芬太尼组3997.34±0.5692.37±0.4294.82±0.6596.62±0.8710.99454.12318.415
芬太尼组3997.40±0.6491.84±0.5093.14±0.5495.25±0.56
t0.4415.06912.4158.269
P0.661<0.001<0.001<0.001<0.001<0.001<0.001
PaO2(mmHg)舒芬太尼组3992.83±6.2585.06±3.9688.25±4.2691.47±5.8812.10248..37420.114
芬太尼组3992.47±5.8482.37±4.1186.01±3.7887.41±6.03
t0.2632.9432.4563.010
P0.7930.0040.0160.004<0.001<0.001<0.001
OI(mmHg)舒芬太尼组39493.25±40.87454.27±30.21470.23±32.41495.26±40.1715.67962.83720.415
芬太尼组39492.44±45.72430.84±25.36452.88±28.99475.36±34.29
t0.0823.7102.4932.353
P0.934<0.0010.0150.021<0.001<0.001<0.001

引文著录: 陈青林, 葛伟炳, 吴刚, 陆叶兰. 舒芬太尼与芬太尼靶控输注对结直肠癌根治术患者麻醉苏醒质量、肺内氧合及氧化抗氧化系统影响的对比研究. 世界华人消化杂志 2024; 32(3): 236-242